顺式凯林内酯通过促进自噬抑制促炎巨噬细胞改善咪喹莫特诱导的银屑病
本研究在咪喹莫特诱导的C57BL/6小鼠银屑病模型中,发现天然小分子顺式凯林内酯可降低皮损中IL-23、TNF-α、IL-1β和IL-6水平,并限制IL-17A的抑制。该药特异性减少真皮巨噬细胞浸润而非中性粒细胞或T细胞,并抑制巨噬细胞NF-κB p65活化,机制上通过促进自噬抑制促炎表型巨噬细胞,且毒性低于甲氨蝶呤。
要点
- 顺式凯林内酯可改善咪喹莫特诱导的小鼠银屑病样皮损。
- 该药选择性减少真皮巨噬细胞浸润并抑制其NF-κB p65活化。
- 其疗效依赖促进巨噬细胞自噬,且毒性低于甲氨蝶呤。
核心结论
- 顺式凯林内酯通过诱导自噬选择性调节巨噬细胞功能和表型,改善咪喹莫特诱导的小鼠银屑病。
研究设计与样本
- 在咪喹莫特诱导的C57BL/6小鼠银屑病模型中评估顺式凯林内酯的治疗效果。
主要发现
- 顺式凯林内酯降低银屑病皮肤中IL-23、TNF-α、IL-1β和IL-6水平,同时限制IL-17A的抑制。
- 顺式凯林内酯特异性减少真皮巨噬细胞浸润,但不影响中性粒细胞或T细胞。
- 顺式凯林内酯显著降低浸润巨噬细胞中NF-κB p65的活化。
- 顺式凯林内酯通过促进自噬抑制促炎表型巨噬细胞。
- 沉默Beclin1或Atg7阻断自噬可消除顺式凯林内酯对巨噬细胞的作用。
临床怎么用
- 顺式凯林内酯可能作为通过靶向巨噬细胞自噬治疗银屑病的候选策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a chronic inflammatory skin disease with unresolved pathogenesis. Studies on the pathogenesis of psoriasis have been extensively carried out, but treatments are still not satisfactory. In this study, we found improvement after treatment with cis-khellactone, a small molecular natural product, in imiquimod-challenged C57BL/6 mice. cis-Khellactone clearly reduced the level of cytokines in psoriatic skin, including IL-23, TNF-α, IL-1β, and IL-6, while limiting the inhibition of IL-17A, which is produced by T helper type 17 cells. cis-Khellactone treatment specifically decreased dermal macrophage infiltration in psoriatic skin but not in neutrophils or T cells. Additionally, compared with the control group, cis-khellactone significantly decreased the activation of NF-κB p65 in these infiltrated macrophages. Further study showed that cis-khellactone suppressed proinflammatory phenotypic macrophages by promoting autophagy. Blocking autophagy by silencing Beclin1 or Atg7 abrogated the effect of cis-khellactone on macrophages. The autophagy-dependent improvement in psoriasis from cis-khellactone treatment was further manifested by its limited effects on skin lesions in chloroquine-treated mice. Moreover, cis-khellactone showed lower toxicity levels than methotrexate in macrophages and primary hepatocytes. Taken together, cis-khellactone selectively modulated macrophage function and phenotype by inducing autophagy to ameliorate imiquimod-induced psoriasis in mice. Our research provides an effective strategy for the treatment of psoriasis.
引用
- Feng L, Song P, Xu F, et al. cis-Khellactone Inhibited the Proinflammatory Macrophages via Promoting Autophagy to Ameliorate Imiquimod-Induced Psoriasis. J Invest Dermatol. 2019. PMID: 30878677. doi:10.1016/j.jid.2019.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。